Background
Methods
Participants
Anthropometric, clinical and socio‑demographic parameters
Biological measurements
Measurements of coronary atherosclerosis
Measurements of intra- and extracranial atherosclerosis
Statistical methods
Results
Baseline characteristics
Characteristics | Total n = 2719 | Tertile1* n = 906 | Tertile2 n = 907 | Tertile3 n = 906 | P value |
---|---|---|---|---|---|
Age(years) | 60.9 ± 6.6 | 61.3 ± 6.7 | 60.9 ± 6.6 | 60.5 ± 6.4 | 0.04 |
Female (n, %) | 1441(53.0) | 465(51.3) | 498(54.9) | 478(52.8) | 0.31 |
Current smoking, n (%) | 566(20.8) | 184(20.3) | 193(21.3) | 189(20.9) | 0.88 |
Current drinking, n (%) | 522(19.2) | 170(18.8) | 171(18.9) | 181(20.0) | 0.77 |
History of comorbidities (n, %) | |||||
Hypertension | 1095(40.3) | 270(29.8) | 364(40.1) | 461(50.9) | < 0.001 |
Dyslipidemia | 533(19.6) | 77(8.5) | 174(19.2) | 282(31.3) | < 0.001 |
TIA | 9(0.3) | 2(0.2) | 6(0.7) | 1(0.1) | 0.10 |
Stroke | 64(2.4) | 24(2.7) | 19(2.1) | 21(2.3) | 0.74 |
Coronary artery disease | 10(0.4) | 4(0.4) | 3(0.3) | 3(0.3) | 0.90 |
Medication history (n, %) | |||||
Lipid-lowering medicine | 90(3.3) | 16(1.8) | 38(4.2) | 36(4.0) | < 0.001 |
Statins | 82(3.0) | 16(1.8) | 35(3.9) | 31(3.4) | 0.02 |
Fibrate | 5(0.2) | 0(0.0) | 2(0.2) | 3(0.3) | 0.23 |
Other | 4(0.2) | 0(0.0) | 1(0.1) | 3(0.3) | 0.17 |
Antihypertensive medications | 667(24.5) | 152(16.8) | 211(23.3) | 304(33.6) | < 0.001 |
BMI (km/m2) | 23.7 ± 2.0 | 22.4 ± 2.9 | 23.9 ± 2.9 | 24.7 ± 2.8 | < 0.001 |
FPG (mmol/L) | 5.66 ± 0.98 | 5.4 ± 0.5 | 5.6 ± 0.7 | 6.0 ± 1.4 | < 0.001 |
Fasting insulin (mmol/L) | 6.2(4.4–8.8) | 4.8(3.4–6.5) | 6.2(4.6–8.7) | 8.1(5.9–10.9) | < 0.001 |
TG (mg/ dL) | 1.7 ± 1.2 | 0.9 ± 0.2 | 1.5 ± 0.2 | 2.9 ± 1.4 | < 0.001 |
eGFR (mL/min/1.73 m2) | 102.3 ± 11.7 | 103.2 ± 10.8 | 101.6 ± 12.3 | 102.1 ± 12.0 | 0.02 |
LDL (mmol/L) | 2.8 ± 0.8 | 2.6 ± 0.7 | 3.0 ± 0.8 | 2.8 ± 0.9 | < 0.001 |
Association of insulin resistance and atherosclerosis
Atherosclerotic plaque | The TyG index | HOMA-IR | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n/N (%) | Model1* OR/cOR(95%CI) | P | Model2† OR/cOR(95%CI) | P | n/N (%) | Model1* OR/cOR(95%CI) | P | Model2† OR/cOR(95%CI) | P | ||
Presence of intracranial plaque | |||||||||||
T1 | 113/906(12.5) | Reference | Reference | 128/906(14.1) | Reference | Reference | |||||
T2 | 148/907(16.3) | 1.42(1.09–1.85) | 0.01 | 1.27(0.96–1.68) | 0.10 | 136/904(15.0) | 1.16(0.89–1.52) | 0.28 | 0.96(0.72–1.27) | 0.75 | |
T3 | 171/906(18.9) | 1.75(1.34–2.27) | < 0.001 | 1.45(1.09–1.92) | 0.01 | 168/909(18.5) | 1.49(1.15–1.94) | 0.003 | 1.06(0.78–1.45) | 0.69 | |
Pre 1-SD | - | 1.26(1.14–1.40) | < 0.001 | 1.19(1.06–1.33) | 0.003 | - | 1.13(1.03–1.24) | 0.01 | 1.01(0.91–1.13) | 0.82 | |
P for trend | - | < 0.001 | 0.01 | - | 0.002 | 0.58 | |||||
Intracranial atherosclerotic burden‡ | |||||||||||
T1 | - | Reference | Reference | - | Reference | Reference | |||||
T2 | - | 1.39(1.06–1.81) | 0.02 | 1.22(0.92–1.61) | 0.16 | - | 1.16(0.89–1.52) | 0.27 | 0.95(0.71–1.26) | 0.70 | |
T3 | - | 1.73(1.33–2.24) | < 0.001 | 1.40(1.06–1.85) | 0.02 | - | 1.49(1.15–1.93) | 0.003 | 1.05(0.78–1.43) | 0.74 | |
Pre 1-SD | - | 1.25(1.13–1.39) | < 0.001 | 1.16(1.04–1.30) | 0.009 | - | 1.12(1.02–1.22) | 0.014 | 0.999(0.89–1.12) | 0.98 | |
P for trend | - | < 0.001 | 0.02 | - | 0.002 | 0.61 | |||||
Presence of extracranial plaque | |||||||||||
T1 | 285/906(31.5) | Reference | Reference | 315/906(34.8) | Reference | Reference | |||||
T2 | 353/907(38.9) | 1.43(1.18–1.74) | < 0.001 | 1.30(1.06–1.60) | 0.01 | 329/904(36.4) | 1.23(1.01–1.51) | 0.04 | 1.17(0.95–1.45) | 0.14 | |
T3 | 337/906(37.2) | 1.33(1.09–1.62) | 0.005 | 1.25(1.01–1.55) | 0.04 | 331/909(36.4) | 1.28(1.05–1.56) | 0.02 | 1.24(0.98–1.57) | 0.07 | |
Pre 1-SD | - | 1.13(1.04–1.22) | 0.003 | 1.12(1.02–1.22) | 0.01 | - | 1.03(0.95–1.11) | 0.49 | 1.01(0.92–1.10) | 0.90 | |
P for trend | - | 0.007 | 0.052 | - | 0.03 | 0.09 | |||||
Extracranial atherosclerotic burden§ | |||||||||||
T1 | - | Reference | Reference | - | Reference | Reference | |||||
T2 | - | 1.43(1.18–1.73) | < 0.001 | 1.31(1.07–1.60) | 0.008 | - | 1.27(1.04–1.54) | 0.02 | 1.22(0.99–1.49) | 0.06 | |
T3 | - | 1.34(1.11–1.63) | 0.003 | 1.28(1.04–1.58) | 0.02 | - | 1.29(1.06–1.57) | 0.01 | 1.27(1.01–1.60) | 0.04 | |
Pre 1-SD | - | 1.14(1.05–1.23) | 0.001 | 1.13(1.04–1.23) | 0.004 | - | 1.03(0.96–1.11) | 0.44 | 1.01(0.93–1.10) | 0.80 | |
P for trend | - | 0.004 | 0.03 | - | 0.02 | 0.06 | |||||
Presence of coronary plaque | |||||||||||
T1 | 328/906(36.2) | Reference | Reference | 356/906(39.3) | Reference | Reference | |||||
T2 | 414/907(45.6) | 1.63(1.33–1.99) | < 0.001 | 1.40(1.13–1.72) | 0.002 | 378/904(41.8) | 1.36(1.11–1.67) | 0.003 | 1.16(0.94–1.44) | 0.17 | |
T3 | 418/906(46.1) | 1.72(1.41–2.09) | < 0.001 | 1.42(1.14–1.76) | 0.002 | 426/909(46.9) | 1.75(1.43–2.15) | < 0.001 | 1.33(1.05–1.69) | 0.02 | |
Pre 1-SD | - | 1.22(1.12–1.32) | < 0.001 | 1.14(1.04–1.24) | 0.002 | - | 1.25(1.13–1.37) | < 0.001 | 1.10(0.99–1.21) | 0.08 | |
P for trend | - | < 0.001 | 0.002 | - | < 0.001 | 0.02 | |||||
Segment stenosis score|| | |||||||||||
T1 | - | Reference | Reference | - | Reference | Reference | |||||
T2 | - | 1.36(1.12–1.66) | 0.002 | 1.23(1.004–1.52) | 0.046 | - | 1.34(1.10–1.64) | 0.004 | 1.21(0.98–1.49) | 0.08 | |
T3 | - | 1.62(1.33–1.97) | < 0.001 | 1.40(1.14–1.73) | 0.002 | - | 1.62(1.33–1.98) | < 0.001 | 1.30(1.03–1.65) | 0.03 | |
Pre 1-SD | - | 1.20(1.11–1.30) | < 0.001 | 1.14(1.05–1.24) | 0.002 | - | 1.20(1.11–1.31) | < 0.001 | 1.11(1.02–1.21) | 0.01 | |
P for trend | - | < 0.001 | 0.002 | - | < 0.001 | 0.04 |
Atherosclerotic plaque | TyG /HOMA-IR | n/N (%) | Model1* | Model2† | ||
---|---|---|---|---|---|---|
OR/cOR(95%CI) | P | OR/cOR(95%CI) | P | |||
Presence of intracranial plaque | Low TyG /Low HOMA-IR | 122/944(12.92) | Reference | Reference | ||
Low TyG /High HOMA-IR | 60/415(14.42) | 1.2(0.85–1.68) | 0.30 | 0.98(0.68–1.42) | 0.93 | |
High TyG /Low HOMA-IR | 73/416(17.59) | 1.45(1.05-2.00) | 0.02 | 1.31(0.94–1.82) | 0.11 | |
High TyG /High HOMA-IR | 177/944(18.75) | 1.66(1.29–2.15) | < 0.001 | 1.28(0.95–1.71) | 0.10 | |
Intracranial atherosclerotic burden‡ | Low TyG /Low HOMA-IR | - | Reference | Reference | ||
Low TyG /High HOMA-IR | - | 1.19(0.85–1.67) | 0.31 | 0.99(0.69–1.42) | 0.96 | |
High TyG /Low HOMA-IR | - | 1.47(1.07–2.02) | 0.02 | 1.31(0.94–1.82) | 0.11 | |
High TyG /High HOMA-IR | - | 1.66(1.28–2.14) | < 0.001 | 1.26(0.94–1.68) | 0.12 | |
Presence of extracranial plaque | Low TyG /Low HOMA-IR | 308/944(32.63) | Reference | Reference | ||
Low TyG /High HOMA-IR | 134/415(32.21) | 1.11(0.87–1.43) | 0.40 | 1.10(0.85–1.44) | 0.47 | |
High TyG /Low HOMA-IR | 173/416(41.69) | 1.39(1.09–1.77) | 0.007 | 1.34(1.04–1.71) | 0.02 | |
High TyG /High HOMA-IR | 360/944(38.14) | 1.39(1.14–1.68) | < 0.001 | 1.35(1.08–1.68) | < 0.001 | |
Extracranial atherosclerotic burden§ | Low TyG /Low HOMA-IR | - | Reference | Reference | ||
Low TyG /High HOMA-IR | - | 1.15(0.90–1.47) | 0.28 | 1.14(0.88–1.48) | 0.33 | |
High TyG /Low HOMA-IR | - | 1.40(1.10–1.76) | 0.005 | 1.35(1.06–1.71) | 0.02 | |
High TyG /High HOMA-IR | - | 1.40(1.16–1.69) | < 0.001 | 1.38(1.11–1.71) | < 0.001 | |
Presence of coronary plaque | Low TyG /Low HOMA-IR | 354/944(37.50) | Reference | Reference | ||
Low TyG /High HOMA-IR | 164/415(39.42) | 1.29(1.001–1.66) | 0.049 | 1.08(0.82–1.42) | 0.58 | |
High TyG /Low HOMA-IR | 195/416(46.99) | 1.46(1.14–1.86) | 0.003 | 1.30(1.01–1.68) | 0.04 | |
High TyG /High HOMA-IR | 447/944(47.35) | 1.78(1.46–2.16) | < 0.001 | 1.40(1.12–1.75) | < 0.001 | |
Segment stenosis score|| | Low TyG /Low HOMA-IR | - | Reference | Reference | ||
Low TyG /High HOMA-IR | - | 1.25(0.97–1.61) | 0.08 | 1.11(0.85–1.45) | 0.44 | |
High TyG /Low HOMA-IR | - | 1.47(1.16–1.88) | 0.001 | 1.39(1.09–1.78) | 0.009 | |
High TyG /High HOMA-IR | - | 1.65(1.36-2.00) | < 0.001 | 1.39(1.11–1.73) | 0.004 |